Business Wire02.21.20
Smiths Medical, a global medical device manufacturer, has launched a new Polyvinyl Chloride (PVC) tracheostomy tube portfolio to its family of tracheostomy tubes. When caring for a patient with a tracheostomy, a tube should be chosen to best suit the patient’s specific clinical need. The new tracheostomy tubes have options for a variety of patients.
“Our goal was to create tracheostomy tubes and kits designed to help clinicians provide the best patient care. We’re excited to offer a variety of tubes and kits that empower clinicians with the ability to practice their way and more importantly, meet their patients’ needs,” said Ellen Frenkel, chief marketing officer.
The Smiths Medical BLUselect tracheotomy tubes include the following new benefits:
The Smiths Medical BLUperc and BLUgriggs percutaneous tracheostomy kits and trays include the following new benefits:
Smiths Medical provides training videos, technique guides, and detailed instructional information for training clinicians on percutaneous insertion.
Last summer, Smiths Medical partnered with Medline Industries for distribution of the Portex acapella choice vibratory PEP therapy device. This enhanced distribution partnership will be focused on the non-acute and home care channels.
“This partnership with Smiths Medical will enhance Medline’s portfolio of patient-centered solutions linked to improved outcomes,” said Tim Finnigan, respiratory division president at Medline. “With these solutions, we can be a better partner to facilities beyond the acute market and across the continuum of care in achieving better patient outcomes and improving consistency of care.”
“The distribution partnership with Medline provides improved access to our acapella choice device for patients within the non-acute and home care settings,” said Nirav Sheth, senior director of Global Marketing and general manager at Smiths Medical. “This is an important channel within the full continuum of care, and we are very excited about what this opportunity brings to Smiths Medical, Medline, and the patients treated in non-acute settings.”
The Smiths Medical Portex acapella choice device is the market-leading vibratory PEP device and is used to mobilize secretions and open airways.
“Our goal was to create tracheostomy tubes and kits designed to help clinicians provide the best patient care. We’re excited to offer a variety of tubes and kits that empower clinicians with the ability to practice their way and more importantly, meet their patients’ needs,” said Ellen Frenkel, chief marketing officer.
The Smiths Medical BLUselect tracheotomy tubes include the following new benefits:
- Tubes are available with or without inner cannula, cuffed or uncuffed, fenestrated or unfenestrated, and Suctionaid for above the cuff suctioning
- Tubes and packaging are color-coded by size
- Laser printing on tubes cannot be altered by secretions or cleaning and include tube characteristics
- Solid color marking indicates the tube is non-fenestrated while checkered color markings indicate the tube is fenestrated
- Tube flanges are soft and bendable to improve patient comfort and simplify cleaning
The Smiths Medical BLUperc and BLUgriggs percutaneous tracheostomy kits and trays include the following new benefits:
- Kits and trays include everything needed to perform the procedure
- Single tray layout matches the steps in the clinical tracheostomy procedure and flow counter-clockwise for efficiency
- Kits and trays include a patented single-handed guidewire feeder that can be used by left or right-handed clinicians
Smiths Medical provides training videos, technique guides, and detailed instructional information for training clinicians on percutaneous insertion.
Last summer, Smiths Medical partnered with Medline Industries for distribution of the Portex acapella choice vibratory PEP therapy device. This enhanced distribution partnership will be focused on the non-acute and home care channels.
“This partnership with Smiths Medical will enhance Medline’s portfolio of patient-centered solutions linked to improved outcomes,” said Tim Finnigan, respiratory division president at Medline. “With these solutions, we can be a better partner to facilities beyond the acute market and across the continuum of care in achieving better patient outcomes and improving consistency of care.”
“The distribution partnership with Medline provides improved access to our acapella choice device for patients within the non-acute and home care settings,” said Nirav Sheth, senior director of Global Marketing and general manager at Smiths Medical. “This is an important channel within the full continuum of care, and we are very excited about what this opportunity brings to Smiths Medical, Medline, and the patients treated in non-acute settings.”
The Smiths Medical Portex acapella choice device is the market-leading vibratory PEP device and is used to mobilize secretions and open airways.